Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.7.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Income Statement [Abstract]    
Other revenue - fee (Note 8) $ 24,175 $ 24,175
Operating expenses:    
Selling, general and administrative 1,034,653 1,030,126
Research and development 17,692 372,586
Total operating expenses 1,052,345 1,402,712
Operating loss from continuing operations (1,028,170) (1,378,537)
Other (expense) income:    
Gain on sale of property and equipment (Note 3) 1,919,361
Interest expense (4,834) (25,598)
Investment income 26,220 44,285
Total other income 21,386 1,938,048
(Loss) income from continuing operations (1,006,784) 559,511
Discontinued operations (Note 2):    
Loss from operations (642,636)
Impairment loss (2,704,356)
Total loss from discontinued operations (3,346,992)
Net income (loss) $ (4,353,776) $ 559,511
Basic and diluted net (loss) income per share (Note 1):    
Continuing operations $ (0.22) $ 0.14
Discontinued operations (0.73)
Net (Loss) Income $ (0.95) $ 0.14
Basic and diluted weighted average number of shares outstanding (Note 1) 4,599,184 3,876,960